{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:24:00Z","timestamp":1648722240099},"reference-count":10,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.neurol.2010.03.005","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T02:10:34Z","timestamp":1274062234000},"page":"752-753","source":"Crossref","is-referenced-by-count":1,"title":["Association de myasth\u00e9nie et de lymphome non hodgkinien extrathymique"],"prefix":"10.1016","volume":"166","author":[{"given":"S.","family":"Koussa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rustom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2010.03.005_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.45.5.1019","article-title":"Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy","volume":"45","author":"Abrey","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.03.005_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.37.8.1405","article-title":"Myasthenia gravis associated with T helper cell lymphoma","volume":"37","author":"Bowen","year":"1987","journal-title":"Neurology."},{"key":"10.1016\/j.neurol.2010.03.005_bib3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00415-006-0171-6","article-title":"Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin's disease","volume":"253","author":"Ferra","year":"2006","journal-title":"J Neurol."},{"key":"10.1016\/j.neurol.2010.03.005_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ajh.20169","article-title":"Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma","volume":"77","author":"Gajra","year":"2004","journal-title":"Am J Hematol."},{"key":"10.1016\/j.neurol.2010.03.005_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0609.1983.tb01524.x","article-title":"A case of malignant lymphoma and myasthenia gravis","volume":"31","author":"Hansen","year":"1983","journal-title":"Cand J Haematol."},{"key":"10.1016\/j.neurol.2010.03.005_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000114680","article-title":"Association between myasthenia gravis and malignant lymphoma","volume":"13","author":"Levo","year":"1975","journal-title":"Eur Neurol."},{"key":"10.1016\/j.neurol.2010.03.005_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/CND.0b013e31819a8403","article-title":"Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3\u00a0cases and review","volume":"10","author":"Nelson","year":"2009","journal-title":"Clin Neuromuscul Dis."},{"key":"10.1016\/j.neurol.2010.03.005_bib8","first-page":"81","article-title":"Myasthenic syndrome disclosing Hodgkin disease","volume":"150","author":"Quilichini","year":"1994","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2010.03.005_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12185-009-0281-x","article-title":"Rare association of Hodgkin lymphoma. Graves\u2019 disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility?","volume":"89","author":"Simon","year":"2009","journal-title":"Int J Hematol."},{"key":"10.1016\/j.neurol.2010.03.005_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00277-005-1050-4","article-title":"Anti-CD20\u00a0antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma","volume":"84","author":"Takagi","year":"2005","journal-title":"Ann Hematol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378710001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378710001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:24:02Z","timestamp":1544487842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378710001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":10,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0035378710001323"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2010.03.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}